NCT07191106Recruiting
Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in Patients With Inflammatory Bowel Disease (IBD)
Pilot Feasibility and Impact Study of a Remote Adapted Physical Activity Program on the Quality of Life of Patients With Inflammatory Bowel Disease (IBD)
Source: ClinicalTrials.gov · Last updated 24 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Inflammatory Bowel Disease (IBD) is a chronic relapsing condition that affects the gastrointestinal tract and is increasingly diagnosed in adolescents and young adults. Although anti-TNFα therapies are effective in reducing disease activity and improving quality of life, they are frequently associated with side effects such as fatigue, weight gain, and joint pain, which may be mitigated by regular physical activity. Emerging evidence suggests that light to moderate physical activity may help reduce systemic and intestinal inflammation and improve IBD-related outcomes. However, access to structured physical activity programs remains limited, and personal or professional constraints may hinder participation. This pilot study aims to assess the feasibility and impact of a remotely delivered Adapted Physical Activity (APA) program on the quality of life of patients with Inflammatory Bowel Disease (IBD), including Crohn's disease and ulcerative colitis. This study evaluates the effects of a 12-weeks remote APA intervention on quality of life as the primary outcome. Secondary objectives include assessing changes in anxiety and depression, fatigue levels, IBD activity, and smoking behavior. The findings from this study may inform the development of scalable, non-pharmacological strategies to support symptom management and well-being in individuals with IBD.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- First submitted
- 21 Jul 2025
- Start date
- 15 Sept 2025
- Primary completion date
- 30 Oct 2025
- Lead sponsor
- Raincy Montfermeil Hospital Group
- Diseases
- Crohn's disease, Ulcerative colitis
- NCT number
- NCT07191106
What you commit to
- Study type: Interventional
- Planned participants: 72
- From 15 Sept 2025 to the primary completion date, 30 Oct 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of psychological disorders that may interfere with study participation
Age
- Patients under 18 years of age
Other
- Medical contraindication to physical activity
- High levels of physical activity as defined by the International Physical Activity Questionnaire (IPAQ):
- Total \>1500 MET-min/week of vigorous activity on at least 3 days, OR
- Total physical activity \>3000 MET-min/week, regardless of distribution
- Lack of access to a device or internet connection enabling remote participation
- Pregnant or breastfeeding women
- Patients under legal guardianship or curatorship
- Patients under legal protection
Who the study is looking for
- Adults aged 18 years and older
- Diagnosis of Inflammatory Bowel Disease (IBD) established for at least 6 months
- Patient is motivated to participate in the Adapted Physical Activity (APA) program
- Medical certificate confirming fitness to engage in remote physical activity
- Access to a digital device with internet connectivity enabling use of the MOOV+ application at home
- Written informed consent freely given after appropriate information
- Affiliation with, or beneficiary of, a national health insurance system
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ghi Le Raincy-Montfermeil Coordinator of this site? Confirm its status | Montfermeil | France | Recruiting |
| CHU Nantes Coordinator of this site? Confirm its status | Nantes | France | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.